Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.43
Delayed Data
As of 3:59pm ET
 -0.27 / -3.10%
Today’s Change
6.97
Today|||52-Week Range
16.30
+17.74%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.70
Today’s open8.56
Day’s range8.35 - 8.77
Volume320,385
Average volume (3 months)576,263
Market cap$350.6M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.09-0.62%
GLYCGlycoMimetics Inc-0.89-6.41%
CRBPCorbus Pharmaceutica...-0.30-4.44%
CCXIChemoCentryx Inc-0.07-1.00%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateJune 12, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts